← Back to Screener
Telix Pharmaceuticals Limited American Depositary Shares (TLX)
Price$9.30
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-14.46%
Price vs S&P 500 (4W)-12.91%
VGM Score59.02
All Metrics
Price vs S&P 500 (YTD)16.01%
10-Day Avg Trading Volume0.20M
3-Month Avg Trading Volume0.23M
52-Week Price Return-46.43%
52-Week High$18.49
26-Week Price Return-6.53%
13-Week Price Return30.43%
3-Month Return Std Dev52.64%
Price vs S&P 500 (52W)-70.79%
Year-to-Date Return24.17%
5-Day Price Return-1.27%
Month-to-Date Return-1.38%
Price vs S&P 500 (13W)22.18%
52-Week Low$6.28
mGradeC
vgmGradeC
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TLXTelix Pharmaceuticals Limited American Depositary Shares | — | — | C | $9.30 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Telix develops radiopharmaceuticals, which combine radioisotopes with targeted molecules to diagnose and treat cancers. The company generates revenue from U.S. sales of Illuccix, a prostate cancer imaging agent, while advancing additional radiopharmaceutical candidates through its pipeline.